Catalent achieves global ISO accreditation

12 May 2019

Company is one of the first CDMOs to receive award.

Catalent has announced that the British Standards Institute (BSI) has awarded Catalent a global accreditation against the international management standards for environment (ISO14001:2015) and occupational safety (OHSAS18001:2007). The accreditation, for Catalent’s global Environment, Health & Safety (EHS) management system is one of the first to be awarded in the pharmaceutical industry to a CDMO.

Catalent achieves global ISO accreditation

BSI’s auditors judged that Catalent’s EHS system demonstrates a high degree of sophistication and maturity, and competes at a world-class performance level with other leading industries and businesses.

“Our EHS system drives our core values of injury prevention and environmental sustainability, and is central to supporting customer and patient expectations,” commented Mark Incledion, Catalent’s Global Director, EHS. He added: “This accreditation is very much in line with Catalent's patient-first and corporate responsibility-driven philosophy, while helping us meet our environmental targets and promote a cleaner planet.”

Catalent’s global network of facilities produce over 70 billion doses annually and are approved by 35 regulatory agencies to provide flexible commercial and clinical manufacturing supplies in oral, sterile, biologic and inhaled dose forms for customers around the world.

Read More

Related news

Improving gut health with human milk oligosaccharides

Improving gut health with human milk oligosaccharides

17 May 2019

2’-FL a very promising agent for digestive health across various age groups beyond infancy.

Read more 
Expert forecasts huge growth in Middle East manufacturing

Expert forecasts huge growth in Middle East manufacturing

16 May 2019

UAE consumers and insurance companies are willing to pay for highest quality drug products.

Read more 
Colorcon's breakthrough for direct compression

Colorcon's breakthrough for direct compression

15 May 2019

New starch-based excipient plays an important role in enhancing the stability of moisture-sensitive APIs.

Read more 
Legacy plans for lyophilisation boom

Legacy plans for lyophilisation boom

14 May 2019

The increase in biologics is driving the growth in demand for lyophilization in vials.

Read more 
Lessons learned from early EU FMD adopters

Lessons learned from early EU FMD adopters

13 May 2019

Data exchange, investment costs, resources and hardware identified as some of the biggest challenges.

Read more 
Vibalogics increases capacity with a new 200-L line for virus manufacturing

Vibalogics increases capacity with a new 200-L line for virus manufacturing

9 May 2019

Company has also invested in an Äkta-ready chromatography system for downstream processing and liquid handling equipment to deal with increased volumes.

Read more 
New SIMCA 16 software for multivariate data analytics

New SIMCA 16 software for multivariate data analytics

8 May 2019

Makes model data easier to interpret for better process control.

Read more 
Recipharm launches its end-to-end inhalation offering

Recipharm launches its end-to-end inhalation offering

7 May 2019

Offers a seamless outsourcing service for inhalation products, including MDIs, DPIs and nasal sprays.

Read more 
Accessible online courses designed to improve tablet compression tooling

Accessible online courses designed to improve tablet compression tooling

7 May 2019

I Holland launches online training for all levels of pharmaceutical and nutraceutical professionals.

Read more 
WuXi AppTec acquisition enhances its biometrics services for clinical development

WuXi AppTec acquisition enhances its biometrics services for clinical development

6 May 2019

Acquisition will help customers to shorten time-to-market of new drugs.

Read more